Recombinant Human BST1 Protein，His

BST-1 (Bone Marrow Stromal Antigen 1) is a type 2 transmembrane protein primarily expressed in hematopoietic and immune cells. It is a member of the NAD+-glycohydrolase family and acts as a key regulator in immune responses and calcium signaling. Research has shown that BST-1 plays a crucial role in the activation of monocytes and macrophages, promoting their function during immune responses. Additionally, its interaction with NAD+ and the subsequent production of cyclic ADP-ribose are pivotal for calcium mobilization, which is essential for various cellular processes, including proliferation, differentiation, and apoptosis. Dysregulation of BST-1 expression has been linked to several pathological conditions, such as chronic inflammation, autoimmune diseases, and certain cancers, highlighting its potential as a therapeutic target. The study of BST-1 recombinant proteins facilitates insights into its structural and functional properties, enabling the exploration of its role in immune regulation and its interactions with other signaling molecules. As researchers investigate the mechanisms of BST-1 in depth, understanding its contributions to immune system dynamics may pave the way for novel intervention strategies in diseases associated with immune dysregulation. Furthermore, the generation of BST-1 recombinant proteins can also aid in the development of diagnostic tools and therapies aimed at modulating immune responses for improved disease management. Overall, the study of BST-1 recombinant proteins offers significant promise in furthering our understanding of immune function and its implications in health and disease.